Evidence map›Paper›PMID 42445615›Full record

ArticleTobacco prevention & cessation2026

Warning and informative messages on e-cigarette package leaflets: A Belgian policy case study for public health policymakers.

Stijn Everaert, Frieda Matthys, Filip Lardon, Sylvie Gérard, Eline Remue

Abstract readEditorial
In one paragraph

Article in Tobacco prevention & cessation, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Stijn EveraertChemical Environmental Factors Group Superior Health Council Brussels Belgium.
Frieda MatthysDepartment of Psychiatry Universitair Ziekenhuis Brussel, Vrije Universiteit Brussel Brussels Belgium.
Filip LardonCenter for Oncological Research University of Antwerp Antwerp Belgium.
Sylvie GérardMental Health Group Superior Health Council Brussels Belgium.
Eline RemueDirectorate General Animals Plants and Food, Federal Public Service Health, Food Chain Safety and Environment Brussels Belgium.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The EU Tobacco Products Directive specifies the types of information required on e-cigarette package leaflets, but leaves further details and design to the Member States. In practice, however, both aspects are largely determined by the industry. This policy case study presents a comprehensive leaflet proposal developed by the Belgian Superior Health Council in collaboration with national tobacco control stakeholders. This multidisciplinary engagement enhances both the content quality and its acceptance among health professionals. The proposal defines formatting requirements for maximum legibility and comprehension across the general population, and structures evidence-based warning and informative messages into five thematic chapters. It aims to prevent vaping initiation among non-smokers and specific vulnerable groups by highlighting both short- and long-term health risks, while providing adult smokers with balanced information on the potential role of e-cigarettes in smoking cessation, preferably under professional supervision. The content should be updated periodically to reflect new scientific evidence, and complemented with evaluation metrics to assess real-world impact (leaflet reach, reader comprehension, behavioral influence). Given that leaflets are poorly to moderately noticed and rarely read, integration with pictorial warnings is recommended, following the relatively successful Canadian model for cigarette package inserts.

Indexed as

e-cigaretteinsertleafletpackageprevention

Identifiers

PMID42445615
PMCPMC13358470

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.